Detalles de la búsqueda
1.
Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice.
Cancer;
127(12): 2015-2024, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33739457
2.
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes.
Eur J Haematol;
91(3): 219-227, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23679560
3.
6q deletion detected by fluorescence in situ hybridization using bacterial artificial chromosome in chronic lymphocytic leukemia.
Eur J Haematol;
91(1): 10-9, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23560441
4.
Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGA.
Oncologist;
17(5): 663-72, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22531362
5.
Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed-refractory multiple myeloma.
Ann Hematol;
90(12): 1449-56, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21437586
6.
ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma.
Eur J Haematol;
84(6): 474-83, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20331733
7.
Thalidomide-dexamethasone versus interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study.
Br J Haematol;
144(5): 653-9, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19036082
8.
Serum C-reactive protein at diagnosis and response to therapy is the most powerful factor predicting outcome of multiple myeloma treated with thalidomide/ anthracycline-based therapy.
Clin Lymphoma Myeloma;
8(5): 294-9, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18854284
9.
Advanced dementia: opinions of physicians and nurses about antibiotic therapy, artificial hydration and nutrition in patients with different life expectancies.
Geriatr Gerontol Int;
17(3): 487-493, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27004847
10.
Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.
Haematologica;
91(1): 133-6, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16434383
11.
Comparison of two regimens for the treatment of elderly patients with acute lymphoblastic leukaemia (ALL).
Leuk Lymphoma;
46(2): 233-8, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15621806
12.
Thalidomide plus oral melphalan compared with thalidomide alone for advanced multiple myeloma.
Hematol J;
5(4): 312-7, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15297847
13.
Artificial nutrition and hydration in terminally ill patients with advanced dementia: opinions and correlates among Italian physicians and nurses.
J Palliat Med;
17(10): 1143-9, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25188766
14.
Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma.
Leuk Lymphoma;
53(9): 1722-7, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22335534
15.
Assessment of vulnerability measures and their effect on survival in a real-life population of multiple myeloma patients registered at Marche Region Multiple Myeloma Registry.
Clin Lymphoma Myeloma Leuk;
12(6): 423-32, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22981966
16.
Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide.
Leuk Lymphoma;
52(5): 776-85, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21338282
17.
Melphalan, prednisone, and thalidomide versus thalidomide, dexamethasone, and pegylated liposomal doxorubicin regimen in very elderly patients with multiple myeloma: a case-match study.
Leuk Lymphoma;
51(8): 1444-9, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20496998
18.
Thalidomide plus oral melphalan for advanced multiple myeloma: a phase II study.
Haematologica;
88(12): 1432-3, 2003 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-14688003
19.
R-COMP 21 for frail elderly patients with aggressive B-cell non-Hodgkin lymphoma: a pilot study.
Leuk Lymphoma;
49(6): 1081-6, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18569635
20.
Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans.
Br J Haematol;
136(5): 729-35, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17233770